Nuclear Medicine in Clinical Diagnoses and Treatment - 3rd Ed 2 Hardbacks

Section 1: Nuclear medicine in tumor diagnosis and therapy Part A: Diagnosis 1. Tumor-seeking radiopharmaceuticals: nature and mechanisms 2 Radionuclide imaging of hepatic tumors 3 PET in lymphoma and malignant melanoma 4 Parathyroid imaging 5 Adrenocortical scintigraphy 6 Gallium scintigraphy in tumor diagnosis and management 7 Thallium-201 chloride: a tumor imaging agent 8 MIBG in the diagnosis of neuroendocrine tumors 9 Peptide receptor scintigraphy in oncology 10 The diagnostic role of radiolabeled antibodies in cancer 11 Cancer cell biology basis for nuclear oncology 12 Differentiated thyroid carcinoma 13 Medullary thyroid cancer 14 Breast scintigraphy 15 Pediatric tumors 16 Functional analysis of cancer therapy effects in other organs 17 The use of intraoperative probes in surgical oncology 18 The sentinel lymph node in surgical oncology 19 FDG PET Imaging of Head and Neck Cancer 20 External Beam Radiotherapy Treatment Planning with PET 21 PET in aerodigestive tumors 22 PET in gynecological tumors (breast, cervical and ovarian) 23 Nuclear medicine imaging in pediatric oncology 24 Positron Emission Tomography (PET) in genitourinary tumors: prostate, bladder, testicular and renal cancer 25 Future clinical applications of PET (amino acid and nucleoside imaging) 26 PET imaging of brain tumors Section 1: Nuclear medicine in tumor diagnosis and therapy Part B: Radionuclide therapy 27 Principles of radionuclide therapy 28 Dosimetric and radiobiological considerations: The MIRD concept 29 Dosimetric and radiobiological considerations: Patient-individual dosimetry 30 Radioiodine therapy of the thyroid: Treatment of benign thyroid diseases 31 Radioiodine therapy of the thyroid: Treatment of thyroid malignancies 32 Phosphorus-32 therapy in myeloproliferative disorders 33 Palliation of bone pain 34 Radioimmunotherapy of hematologic neoplasms 35 Radioimmunotherapy of solid tumors 36 MIBG therapy 37 Receptor-targeted radiopeptide therapy 38 Use of radiolipiodol in the treatment of hepatic tumours 39 Alternative approaches to targeting therapy 40 New developments: Nuclear gene therapy 41 Atlas 1: PET and PET/CT 42 Atlas 2: SPET and SPET/CT Section 2: Nuclear medicine in disorders of bones and joints 43 Bone scintigraphy: the procedure and interpretation 44 Evaluation of primary bone tumors 45 The evaluation of malignancy: metastatic bone disease 46 Assessment of infection 47 Radionuclide assessment of the painful joint prosthesis 48 Vascular manifestations 49 Bone scintigraphy in trauma 50 Bone scintigraphy in sports medicine 51 Growth and metabolic disorders 52 Arthritis: current status of scintigraphy and future trends 53 Radiation synovectomy Section 3: Quantitative studies of gastrointestinal function 54 Salivary gland disorders 55 Esophageal function (transport and motility) 56 Gastric motility 57 Intestines: evaluation of absorption 58 Studies of small bowel and colonic transit 59 Hepatobiliary function: biliary kinetics 60 Scintigraphic measurement of hepatic function Section 4: Nuclear medicine in acute care 61 Nuclear cardiology and cardiac transplantation 62 Cardiovascular conditions: venous thrombosis 63 Pulmonary embolism 64 Non-embolic disease of the lungs 65 Gastrointestinal bleeding 66 Cholescintigraphy 67 Neonatal hyperbilirubinemia 68 Nuclear medicine in acute care of neurological patients 69 Radiolabeled agents for the localization ...

Inhaltsverzeichnis

Section 1: Nuclear medicine in tumor diagnosis and therapy

Part A: Diagnosis

1. Tumor-seeking radiopharmaceuticals: nature and mechanisms

2 Radionuclide imaging of hepatic tumors

3 PET in lymphoma and malignant melanoma

4 Parathyroid imaging

5 Adrenocortical scintigraphy

6 Gallium scintigraphy in tumor diagnosis and management

7 Thallium-201 chloride: a tumor imaging agent

8 MIBG in the diagnosis of neuroendocrine tumors

9 Peptide receptor scintigraphy in oncology

10 The diagnostic role of radiolabeled antibodies in cancer

11 Cancer cell biology basis for nuclear oncology

12 Differentiated thyroid carcinoma

13 Medullary thyroid cancer

14 Breast scintigraphy

15 Pediatric tumors

16 Functional analysis of cancer therapy effects in other organs

17 The use of intraoperative probes in surgical oncology

18 The sentinel lymph node in surgical oncology

19 FDG PET Imaging of Head and Neck Cancer

20 External Beam Radiotherapy Treatment Planning with PET

21 PET in aerodigestive tumors

22 PET in gynecological tumors (breast, cervical and ovarian)

23 Nuclear medicine imaging in pediatric oncology

24 Positron Emission Tomography (PET) in genitourinary tumors: prostate, bladder, testicular and renal cancer

25 Future clinical applications of PET (amino acid and nucleoside imaging)

26 PET imaging of brain tumors

Section 1: Nuclear medicine in tumor diagnosis and therapy

Part B: Radionuclide therapy

27 Principles of radionuclide therapy

28 Dosimetric and radiobiological considerations: The MIRD concept

29 Dosimetric and radiobiological considerations: Patient-individual dosimetry

30 Radioiodine therapy of the thyroid: Treatment of benign thyroid diseases

31 Radioiodine therapy of the thyroid: Treatment of thyroid malignancies

32 Phosphorus-32 therapy in myeloproliferative disorders

33 Palliation of bone pain

34 Radioimmunotherapy of hematologic neoplasms

35 Radioimmunotherapy of solid tumors

36 MIBG therapy

37 Receptor-targeted radiopeptide therapy

38 Use of radiolipiodol in the treatment of hepatic tumours

39 Alternative approaches to targeting therapy

40 New developments: Nuclear gene therapy

41 Atlas 1: PET and PET/CT

42 Atlas 2: SPET and SPET/CT

Section 2: Nuclear medicine in disorders of bones and joints

43 Bone scintigraphy: the procedure and interpretation

44 Evaluation of primary bone tumors

45 The evaluation of malignancy: metastatic bone disease

46 Assessment of infection

47 Radionuclide assessment of the painful joint prosthesis

48 Vascular manifestations

49 Bone scintigraphy in trauma

50 Bone scintigraphy in sports medicine

51 Growth and metabolic disorders

52 Arthritis: current status of scintigraphy and future trends

53 Radiation synovectomy

Section 3: Quantitative studies of gastrointestinal function

54 Salivary gland disorders

55 Esophageal function (transport and motility)

56 Gastric motility

57 Intestines: evaluation of absorption

58 Studies of small bowel and colonic transit

59 Hepatobiliary function: biliary kinetics

60 Scintigraphic measurement of hepatic function

Section 4: Nuclear medicine in acute care

61 Nuclear cardiology and cardiac transplantation

62 Cardiovascular conditions: venous thrombosis

63 Pulmonary embolism

64 Non-embolic disease of the lungs

65 Gastrointestinal bleeding

66 Cholescintigraphy

67 Neonatal hyperbilirubinemia

68 Nuclear medicine in acute care of neurological patients

69 Radiolabeled agents for the localization of infection and inflammation

70 Undiagnosed fever

71 Inflammatory bowel disease

72 Nuclear imaging in cardiovascular infection and cardiac transplant rejection

73 The immunocompromised patient

Section 5: Nuclear cardiology

74 Radiopharmaceuticals for the study of the heart

75 Radionuclide ventriculography and the assessment of impaired ventricula

Produktdetails

• Autoren: Peter Ell, Peter J. Ell, Peter Josef Ell, Sam Gambhir, Sam (Director Gambhir
• Verlag: Churchill Livingstone
• Sprache: Englisch
• Produktform: Fester Einband
• Erschienen: 15.07.2004
• EAN: 9780443073120
• ISBN: 978-0-443-07312-0
• Abmessung: 230 mm x 285 mm x 60 mm
• Themen: Naturwissenschaften, Medizin, Informatik, Technik > Medizin; Schule und Lernen > Unterrichtsvorbereitung > Berufliche Bildung